CLAVAREZZA, MATTEO
CLAVAREZZA, MATTEO
100008 - Dipartimento di medicina sperimentale
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: Experience from the italian observational NEMESI study
2012-01-01 Clavarezza, M; Mustacchi, G; Gardini, A C; Del Mastro, L; De Matteis, A; Riccardi, F; Adamo, V; Aitini, E; Amoroso, D; Marchetti, P; Gori, S; Carrozza, F; Maiello, E; Giotta, F; Dondi, D; Venturini, M.
Drug-induced thrombocytopenia in a patient with colorectal cancer: A case report
2023-01-01 Pasquariello, S.; Clavarezza, M.; Piredda, S.; Foppiani, L.; Pesce, G.; Antonucci, G.; De Censi, A.; Mattioli, F.
Home se-cure: A home care service for cancer patients during the COVID-19 pandemic
2021-01-01 Webber, Tb; Giuliano, S; Patrone, C; Briata, Im; Franconeri, M; Marceca, F; Magnani, M; Paciolla, F; Provinciali, N; Defferrari, C; Clavarezza, M; D'Amico, M; Gozza, A; Boitano, M; Alessio Mazzola, M; Cevasco, I; Decensi, A
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial
2016-01-01 Lambertini, M; Bruzzi, P; Poggio, F; Pastorino, S; Gardin, G; Clavarezza, Matteo; Bighin, C; Pronzato, P; Del Mastro, L
Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer
2013-01-01 Clavarezza, M; Turazza, M; Aitini, E; Saracchini, S; Garrone, O; Durando, A; De Placido, S; Bisagni, G; Levaggi, A; Bighin, C; Restuccia, E; Scalamogna, R; Galli, A; Del Mastro, L
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole
2013-01-01 Lunardi, G; Piccioli, P; Bruzzi, P; Notaro, R; Lastraioli, S; Serra, M; Marroni, P; Bighin, C; Mansutti, M; Puglisi, F; Porpiglia, M; Ponzone, R; Bisagni, G; Garrone, O; Cavazzini, G; Clavarezza, M; Del Mastro, L
Precision fluoropyrimidines dosing in a compound heterozygous variant carrier of the DPYD gene: a case report
2023-01-01 Baiardi, Giammarco; Clavarezza, Matteo; Stella, Manuela; Casazza, Stefania; DE CENSI, Andrea; Mattioli, Francesca
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment
2021-01-01 Buttiron Webber, T.; Provinciali, N.; Musso, M.; Ugolini, M.; Boitano, M.; Clavarezza, M.; D'Amico, M.; Defferrari, C.; Gozza, A.; Briata, I. M.; Magnani, M.; Paciolla, F.; Menghini, N.; Marcenaro, E.; De Palma, R.; Sacchi, N.; Innocenti, L.; Siri, G.; D'Ecclesiis, O.; Cevasco, I.; Gandini, S.; Decensi, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: Experience from the italian observational NEMESI study | 1-gen-2012 | Clavarezza, M; Mustacchi, G; Gardini, A C; Del Mastro, L; De Matteis, A; Riccardi, F; Adamo, V; Aitini, E; Amoroso, D; Marchetti, P; Gori, S; Carrozza, F; Maiello, E; Giotta, F; Dondi, D; Venturini, M. | |
| Drug-induced thrombocytopenia in a patient with colorectal cancer: A case report | 1-gen-2023 | Pasquariello, S.; Clavarezza, M.; Piredda, S.; Foppiani, L.; Pesce, G.; Antonucci, G.; De Censi, A.; Mattioli, F. | |
| Home se-cure: A home care service for cancer patients during the COVID-19 pandemic | 1-gen-2021 | Webber, Tb; Giuliano, S; Patrone, C; Briata, Im; Franconeri, M; Marceca, F; Magnani, M; Paciolla, F; Provinciali, N; Defferrari, C; Clavarezza, M; D'Amico, M; Gozza, A; Boitano, M; Alessio Mazzola, M; Cevasco, I; Decensi, A | |
| Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial | 1-gen-2016 | Lambertini, M; Bruzzi, P; Poggio, F; Pastorino, S; Gardin, G; Clavarezza, Matteo; Bighin, C; Pronzato, P; Del Mastro, L | |
| Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer | 1-gen-2013 | Clavarezza, M; Turazza, M; Aitini, E; Saracchini, S; Garrone, O; Durando, A; De Placido, S; Bisagni, G; Levaggi, A; Bighin, C; Restuccia, E; Scalamogna, R; Galli, A; Del Mastro, L | |
| Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole | 1-gen-2013 | Lunardi, G; Piccioli, P; Bruzzi, P; Notaro, R; Lastraioli, S; Serra, M; Marroni, P; Bighin, C; Mansutti, M; Puglisi, F; Porpiglia, M; Ponzone, R; Bisagni, G; Garrone, O; Cavazzini, G; Clavarezza, M; Del Mastro, L | |
| Precision fluoropyrimidines dosing in a compound heterozygous variant carrier of the DPYD gene: a case report | 1-gen-2023 | Baiardi, Giammarco; Clavarezza, Matteo; Stella, Manuela; Casazza, Stefania; DE CENSI, Andrea; Mattioli, Francesca | |
| Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment | 1-gen-2021 | Buttiron Webber, T.; Provinciali, N.; Musso, M.; Ugolini, M.; Boitano, M.; Clavarezza, M.; D'Amico, M.; Defferrari, C.; Gozza, A.; Briata, I. M.; Magnani, M.; Paciolla, F.; Menghini, N.; Marcenaro, E.; De Palma, R.; Sacchi, N.; Innocenti, L.; Siri, G.; D'Ecclesiis, O.; Cevasco, I.; Gandini, S.; Decensi, A. |